| Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy Gisen Group The Lancet 349 (9069), 1857-1863, 1997 | 1533 | 1997 |
| Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study C Zoccali, SM Bode-Böger, F Mallamaci, FA Benedetto, G Tripepi, ... The Lancet 358 (9299), 2113-2117, 2001 | 1330 | 2001 |
| Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria P Ruggenenti, A Perna, G Gherardi, G Garini, C Zoccali, M Salvadori, ... The Lancet 354 (9176), 359-364, 1999 | 1139 | 1999 |
| Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease C Zoccali, F Mallamaci, G Tripepi, FA Benedetto, S Cutrupi, S Parlongo, ... Journal of the American Society of Nephrology 13 (1), 134-141, 2002 | 1134 | 2002 |
| Oxidative stress in end‐stage renal disease: an emerging threat to patient outcome F Locatelli, B Canaud, KU Eckardt, P Stenvinkel, C Wanner, C Zoccali Nephrology Dialysis Transplantation 18 (7), 1272-1280, 2003 | 1043 | 2003 |
| Obesity and kidney disease: hidden consequences of the epidemic CP Kovesdy, S Furth, C Zoccali, World Kidney Day Steering Committee Physiology international 104 (1), 1-14, 2017 | 823 | 2017 |
| Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial P Ruggenenti, A Perna, G Loriga, M Ganeva, B Ene-Iordache, M Turturro, ... The Lancet 365 (9463), 939-946, 2005 | 773 | 2005 |
| A single number for advocacy and communication—worldwide more than 850 million individuals have kidney diseases KJ Jager, C Kovesdy, R Langham, M Rosenberg, V Jha, C Zoccali Nephrology Dialysis Transplantation 34 (11), 1803-1805, 2019 | 744 | 2019 |
| Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease C Zoccali, F Mallamaci, S Parlongo, S Cutrupi, FA Benedetto, G Tripepi, ... Circulation 105 (11), 1354-1359, 2002 | 742 | 2002 |
| Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial R Thadhani, E Appelbaum, Y Pritchett, Y Chang, J Wenger, H Tamez, ... Jama 307 (7), 674-684, 2012 | 676 | 2012 |
| When do we need competing risks methods for survival analysis in nephrology? M Noordzij, K Leffondré, KJ van Stralen, C Zoccali, FW Dekker, KJ Jager Nephrology Dialysis Transplantation 28 (11), 2670-2677, 2013 | 668 | 2013 |
| CKD prevalence varies across the European general population K Brück, VS Stel, G Gambaro, S Hallan, H Völzke, J Ärnlöv, M Kastarinen, ... Journal of the American Society of Nephrology 27 (7), 2135-2147, 2016 | 659 | 2016 |
| Vitamin D levels and patient outcome in chronic kidney disease P Ravani, F Malberti, G Tripepi, P Pecchini, S Cutrupi, P Pizzini, ... Kidney international 75 (1), 88-95, 2009 | 586 | 2009 |
| Sample size calculations: basic principles and common pitfalls M Noordzij, G Tripepi, FW Dekker, C Zoccali, MW Tanck, KJ Jager Nephrology dialysis transplantation 25 (5), 1388-1393, 2010 | 562 | 2010 |
| Subjective global assessment of nutrition in dialysis patients G Enia, C Sicuso, G Alati, C Zoccali, D Pustorino, A Biondo Nephrology Dialysis Transplantation 8 (10), 1094-1098, 1993 | 562 | 1993 |
| Confounding: what it is and how to deal with it KJ Jager, C Zoccali, A Macleod, FW Dekker Kidney international 73 (3), 256-260, 2008 | 519 | 2008 |
| Results from the ERA-EDTA Registry indicate a high mortality due to COVID-19 in dialysis patients and kidney transplant recipients across Europe KJ Jager, A Kramer, NC Chesnaye, C Couchoud, JE Sánchez-Álvarez, ... Kidney international 98 (6), 1540-1548, 2020 | 511 | 2020 |
| Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure A Ortiz, A Covic, D Fliser, D Fouque, D Goldsmith, M Kanbay, F Mallamaci, ... The lancet 383 (9931), 1831-1843, 2014 | 507 | 2014 |
| Asymmetric dimethylarginine, C-reactive protein, and carotid intima-media thickness in end-stage renal disease C Zoccali, FA Benedetto, R Maas, F Mallamaci, G Tripepi, LS Malatino, ... Journal of the American Society of Nephrology 13 (2), 490-496, 2002 | 491 | 2002 |
| Asymmetrical dimethylarginine predicts progression to dialysis and death in patients with chronic kidney disease: a competing risks modeling approach P Ravani, G Tripepi, F Malberti, S Testa, F Mallamaci, C Zoccali Journal of the American Society of Nephrology 16 (8), 2449-2455, 2005 | 483 | 2005 |
Francesca MallamaciDirigente Medico UO di Nefrologia e Trapianto, Reggio Cal e CNR-IBIM, Reggio Cal.Verified email at ibim.cnr.it
